Talphera Inc. (TLPH)

[Bobwins]

well, I thought press conference was a success. Early indications are good as company is moving up plans to hire the next 25 account managers to Q3 instead of Q4. As I suspected, hospitals are big institutions with committees to approve/decline new drugs. This is going to take some time for actual sales and new procedures to be implemented.

However ACRX did up guidance from 100 to 125 formulary wins at hospitals over the rest of the year. They have already shipped initial shipments to wholesalers but until they get the formulary wins and the hospitals are ready to train staff on new procedures, actual sales will wait.

Even then, it will take some time for hospitals to get initial supplies, install their procedures and then use Dsuvia. Actual success of the drug will depend on actual usage AND reorder amounts and frequency of reorders.

We still have several quarters before we will know if Dsuvia is a commercial success. Initial indications look good to me and ACRX is not hyping but being quite practical and conservative. I will hold until more actual results come in over the next several months. Looks like premarket there will be a modest drop in the stock price.